This 1995 preclinical study investigated the therapeutic potential of lipoic acid (LA) in a streptozotocin-induced rat model of diabetic neuropathy. LA was administered intraperitoneally at doses of 20, 50, and 100 mg/kg, five times per week. The treatment significantly enhanced nerve blood flow, restored reduced glutathione levels, and improved distal